Drug · DIN 02438534 · Veterinary
OSURNIA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 6, 2021; first marketed November 2, 2015.
- Drug Identification Number (DIN)
- 02438534
- Company (DIN owner)
- Dechra LtdSkipton, North Yorkshire, United Kingdom
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Otic
- Class
- Veterinary
- Record last updated
- June 5, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAMETHASONE ACETATE | 1 MG | ML |
| FLORFENICOL | 10 MG | ML |
| TERBINAFINE | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 16, 2020: NOC 24232New Drug Submission (NDS) · Change in product ownership
- March 16, 2020: NOC 23338Supplement to a New Drug Submission (SNDS) · Addition of drug manufacturing and testing site
- March 12, 2019: NOC 21962Supplement to a New Drug Submission (SNDS) · Addition of drug substance manufacturing and testing site
- March 26, 2015: NOC 16723New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “osurnia”. A notice may cover another product or only some lots: read it to see what it covers.
- Osurnia gel (2018-10-04)October 4, 2018 · Drugs - Veterinary drugs · Product safety · Type II